Form CORRESP - Correspondence:
SEC Accession No. 0001628280-18-000293
Filing Date
2018-01-11
Accepted
2018-01-11 17:07:08
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 11572
2 cumberlanda08.gif GRAPHIC 10657
  Complete submission text file 0001628280-18-000293.txt   27231
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations